Charles M. Baum
Overview
Charles M. Baum received an average of $3M in total compensation, including $498K in salary, at Mirati Therapeutics from 2012 to 2019.
2019Mirati TherapeuticsPresident and Chief Executive Officer
2018Mirati TherapeuticsPresident and Chief Executive Officer
2017Mirati TherapeuticsPresident and Chief Executive Officer
2016Mirati TherapeuticsPresident and Chief Executive Officer
2015Mirati TherapeuticsPresident and Chief Executive Officer
2014Mirati TherapeuticsPresident and Chief Executive Officer
2013Mirati TherapeuticsPresident and Chief Executive Officer
2012Mirati TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 17, 2020, April 19, 2019, April 20, 2018, April 20, 2017, April 19, 2016, April 23, 2015, and April 17, 2014.
Related executives
We found five more executives who work or worked at Mirati Therapeutics.
James Christensen
Mirati Therapeutics
Chief Scientific Officer
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
Chris LeMasters
Mirati Therapeutics
Former Executive Vice President and Chief Business Officer
Mark Gergen
Mirati Therapeutics